RAPT Therapeutics, Inc.RAPTNASDAQ
Loading
Operating Cash Flow Growth AcceleratingAccelerating
Percentile Rank100
Studio
Year-over-Year Change

Year-over-year operating cash flow growth rate

Latest
14.17%
↑ 185% vs avg
Percentile
P100
Near historical high
Streak
1 yr
Consecutive growthAccelerating
Average
-16.62%
Historical baseline
PeriodValue
202414.17%
2023-37.13%
2022-15.97%
2021-50.71%
2020-14.14%
2019-7.65%
2018-21.49%
20170.00%